Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer

— Findings Show Higher Levels of Th7R Immune Cells in the Blood, Suggesting Higher Response to Immunotherapy Due to R-1 EPS, a Metabolite Produced by Lactobacillus Bulgaricus OLL1073R–1 — — Results Presented at American Association for Cancer Research (AACR) Annual Meeting 2026 — TOKYO,...